Insights from the IPF-PRO Registry. Read Article Category: NewsBy Murali RamaswamyJuly 30, 2019Post navigationPreviousPrevious post:PulmonIx wins 5 star patient care awardNextNext post:A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary FibrosisRelated PostsPULMONIX VOLUNTEERS WITH THE KELLIN FOUNDATION TO SUPPORT FAMILIES IN NEEDJuly 18, 2025PULMONIX NAMED FINALIST FOR TRIAD BUSINESS JOURNAL’S BEST PLACES TO WORKMay 29, 2025PULMONIX CELEBRATES CLINICAL TRIALS DAY WITH DR. MARY JO CAGLEMay 20, 2025PULMONIX LEADERSHIP HONORED AT TRIAD BUSINESS JOURNAL C-SUITE AWARDSAugust 29, 2024